What is AFCR?
The Asian Fund for Cancer Research Limited (AFCR) is committed to funding cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients.
Our Research Projects
AFCR is dedicated to sponsoring and supporting innovative research projects that unlock new information about how cancer forms and spreads, and, most importantly, how to treat it.
The State of Cancer Research
Cancer research is about much more than just the scientists, physicians, and nurses who are continuing decades of exploration; it benefits millions of patients and survivors in the form of innovative treatments, screening methods, and promising developments.
We are making great progress against cancer, but there is still more to be done. And you can help.
Latest News
-
Asian Fund for Cancer Research (AFCR) commends Dr. Yung-Chi Cheng’s three decades of pioneering research and celebrates Yiviva’s recent partnership with AstraZeneca China
The Asian Fund for Cancer Research (AFCR) proudly recognizes the exceptional contributions of Dr. Yung-Chi Cheng, AFCR Scientific Advisory Board Member, and Henry Bronson Professor of Pharmacology and Medicine at…
-
Join us on World Cancer Day!
Did you know that there were 9.5 million newly reported cancer cases and 5.8 million cancer-related deaths occurring in Asia in 2020? These numbers are devastating! Even worse, without intervention,…
-
Asian Fund for Cancer Research Announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
HONG KONG – The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition. AFCR’s…